Product Information
ABILIFY 15 MG TABLET is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $18.6178 per EA under NDC 59148000913. Its NADAC has been published 597 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the ARIPIPRAZOLE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Otsuka America Pharmaceutical Inc.NDC
59148000913
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA021436On Market Since
11/15/2002
Pharmacological Classes
Price Statistics
The NADAC for ABILIFY 15 MG TABLET has been published 597 times since Nov 28, 2013, and over the history we have for it it has declined 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.6178 per EA |
|---|---|
| All-time high | $29.0390 (Oct 14, 2015) |
| All-time low | $18.5783 (Apr 22, 2026) |
| 52-week high | $18.6479 |
| 52-week low | $18.5783 |
| Median price | $28.5545 |
| Average price | $25.2386 |
| Largest weekly change | -23.0% (Oct 6, 2021) |
| Weeks tracked | 597 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABILIFY 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABILIFY 15 MG TABLET, manufactured by Otsuka America Pharmaceutical Inc., is $18.6178 per EA (NDC 59148000913), effective Jun 24, 2026.
How has the price of ABILIFY 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABILIFY 15 MG TABLET has declined 14.5%. It has been tracked across 597 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ABILIFY 15 MG TABLET?
Since Nov 28, 2013, the NADAC for ABILIFY 15 MG TABLET has ranged from a low of $18.5783 (Apr 22, 2026) to a high of $29.0390 (Oct 14, 2015), with a median of $28.5545 per EA.
Are there cheaper alternatives to ABILIFY 15 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ARIPIPRAZOLE 15 MG TABLET, is $0.1356 per EA — about 99% below ABILIFY 15 MG TABLET.
Who manufactures ABILIFY 15 MG TABLET?
ABILIFY 15 MG TABLET (NDC 59148000913) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification